AstraZeneca Expands Emphasis On China, Already A Key Market

 
• By Joseph Haas
  
China map
AstraZeneca increases its efforts in China with $2.5bn commitment in Beijing (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Market Access